Cocrystal Pharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q2 2024 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q3 2024 | 1 | -$0.57 | -$0.57 | -$0.57 |
| Q4 2024 | 3 | -$0.60 | -$0.54 | -$0.56 |
| Q1 2025 | 2 | -$0.64 | -$0.60 | -$0.62 |
| Q2 2025 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q3 2025 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q4 2025 | 1 | -$0.48 | -$0.48 | -$0.48 |
Cocrystal Pharma, Inc. Earnings Date And Information
Cocrystal Pharma, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.53 earnings per share for the quarter, missing analysts' consensus estimates of $-0.51 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cocrystal Pharma, Inc. has generated $-2 earnings per share over the last year ($-1.86 diluted earnings per share) and currently has a price-to-earnings ratio of -1.2. Cocrystal Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Cocrystal Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.49 | $0 | $0 | ||
| 08/14/2024 | Q2 2024 | -$0.51 | -$0.53 | -0.02 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$0.54 | -$0.39 | 0.15 | $0 | |
| 03/28/2024 | Q4 2023 | -$0.57 | -$0.44 | 0.13 | $144,000 | |
| 11/13/2023 | Q3 2023 | -$0.47 | -$0.41 | 0.06 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.53 | -$0.41 | 0.12 | $266,667 | $0 |
| 05/15/2023 | Q1 2023 | -$0.59 | -$0.65 | -0.06 | $0 | |
| 03/29/2023 | Q4 2022 | -$0.72 | -$0.55 | 0.17 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.49 | -$0.70 | -0.21 | $83,333 | $0 |
| 08/15/2022 | Q2 2022 | -$0.48 | -$5.55 | -5.07 | $83,333 | $0 |
| 05/11/2022 | Q1 2022 | -$0.48 | -$0.52 | -0.04 | $0 | |
| 03/23/2022 | Q4 2021 | -$0.48 | -$0.51 | -0.03 | $5,427 | |
| 11/15/2021 | Q3 2021 | -$0.48 | -$0.49 | -0.01 | $275,000 | $0 |
| 08/16/2021 | Q2 2021 | -$0.48 | -$0.53 | -0.05 | $275,000 | $0 |
| 05/17/2021 | Q1 2021 | -$0.48 | -$0.46 | 0.02 | $0 | |
| 03/17/2021 | Q4 2020 | -$0.48 | -$0.31 | 0.17 | $510,000 | |
| 11/13/2020 | Q3 2020 | -$0.56 | $560,000 | $489,000 | ||
| 08/06/2020 | Q2 2020 | -$0.48 | -$0.80 | -0.32 | $500,000 | $554,000 |
| 05/13/2020 | Q1 2020 | -$0.57 | $461,000 | |||
| 03/27/2020 | Q4 2019 | -$0.84 | -$13.78 | -12.94 | $402,000 |
Cocrystal Pharma, Inc. Earnings: Frequently Asked Questions
-
When is Cocrystal Pharma, Inc.'s earnings date?
Cocrystal Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
-
How can I listen to Cocrystal Pharma, Inc.'s earnings conference call?
The conference call for Cocrystal Pharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Cocrystal Pharma, Inc.'s conference call transcript?
The conference call transcript for Cocrystal Pharma, Inc.'s latest earnings report can be read online.
-
How much profit does Cocrystal Pharma, Inc. generate each year?
Cocrystal Pharma, Inc. (:COCP) has a recorded net income of $0. Cocrystal Pharma, Inc. has generated $-1.86 earnings per share over the last four quarters.
-
What is Cocrystal Pharma, Inc.'s price-to-earnings ratio?
Cocrystal Pharma, Inc. (:COCP) has a price-to-earnings ratio of -1.2 and price/earnings-to-growth ratio is 0.26.
